LAUREN LEACH: Open Payments
NPI 1285492140 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,644 in 161 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,246 · 2025 $3,644
Food & beverage: $3,644
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $1,161 |
| Janssen Biotech, Inc. | 19 | $499 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $312 |
| Madrigal Pharmaceuticals | 6 | $247 |
| Ardelyx, Inc. | 12 | $245 |
| Regeneron Healthcare Solutions, Inc. | 7 | $191 |
| Medtronic, Inc. | 2 | $168 |
| Aimmune Therapeutics, Inc. | 10 | $162 |
| Celltrion USA Inc. | 13 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
Products named: SKYRIZI, TREMFYA, RINVOQ, XIFAXAN, REZDIFFRA, IBSRELA, DUPIXENT, INTERSTIM.
Industry payments across SC — which companies pay providers there.
